An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population
about
Hepatitis E Seroprevalence in Europe: A Meta-AnalysisEpidemiology of Hepatitis E Virus in European CountriesHepatitis E in Germany--an under-reported infectious diseaseHepatitis E Virus in Industrialized Countries: The Silent ThreatHepatitis E virus seroprevalence among the general population in a livestock-dense area in the Netherlands: a cross-sectional population-based serological surveyHepatitis E and blood donation safety in selected European countries: a shift to screening?Hepatitis E virus antibody prevalence in hunters from a district in Central Germany, 2013: a cross-sectional study providing evidence for the benefit of protective gloves during disembowelling of wild boarsDiagnostic Performance of Five Assays for Anti-Hepatitis E Virus IgG and IgM in a Large Cohort StudyMonitoring of Anti-Hepatitis E Virus Antibody Seroconversion in Asymptomatically Infected Blood Donors: Systematic Comparison of Nine Commercial Anti-HEV IgM and IgG AssaysA Comparative Study of Assay Performance of Commercial Hepatitis E Virus Enzyme-Linked Immunosorbent Assay Kits in Australian Blood Donor Samples.Hepatitis E virus infection.Hepatitis E virus seroprevalence in Austrian adults: a nationwide cross-sectional study among civilians and military professionals.Hepatitis e virus: current concepts and future perspectives.Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection.Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland.Hepatitis E virus serology and PCR: does the methodology matter?Performance of Hepatitis E Virus (HEV)-antibody tests: a comparative analysis based on samples from individuals with direct contact to domestic pigs or wild boar in Germany.Hepatitis E virus RNA in Australian blood donations.Hepatitis E in patients with hepatic disorders and HIV-infected patients in Croatia: is one diagnostic method enough for hepatitis E diagnosis?Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany.Seroprevalence of hepatitis E virus in domestic pigs and wild boars in Switzerland.Hepatitis E VirusThe emergence of hepatitis E virus in Europe
P2860
Q26742017-CAF84D2E-A6B1-4BDB-B537-6B1DD8DE6B1AQ26777824-EF6ECF7E-E939-4DB4-AE24-F32EF1450205Q27002938-72EE41EF-83C2-461B-B936-72D9B769E9C9Q28354374-D8F54043-54F7-4524-A34F-69625B165CABQ28359833-BE82996F-EE3C-49C1-82F1-8074B8896E3EQ33601663-4ACA0402-181F-4736-B0DE-8F8ACCBE3E2CQ35818028-BCB506DD-578D-4131-A0C0-544343315437Q36620859-DB20EB1C-7225-4B7D-B35E-5E9BE9372EA0Q37203189-DE7F2578-7543-45D5-9C31-C81CAB3EC647Q37424582-3E873E0D-937D-43A1-81C3-AFE1D671DE2CQ37544935-8E0E6F26-87B3-4035-9CC7-BBC32FD9A73CQ37548783-1C3AF4F6-C0CC-454E-9D6A-04D2254AD7E4Q38192527-3331C7A3-69F6-48DE-A28D-0D7D684C8FBBQ38469929-AEB34452-E829-4F1F-B9CF-3833D497710AQ40073557-6BA18CDB-5674-49CE-9632-B3E9BA47A290Q40195492-C959C142-4271-46EA-B395-572E1DA3125FQ40248978-908EF4F3-9531-4216-BE20-B102190A5697Q40499922-B03A3691-504A-49A3-925B-7D30B9053608Q42206956-7C598531-6601-4AA9-8A40-DED58807AA8AQ42223774-5E5843B5-70B3-4EB2-8662-58E68903123BQ42238945-D49F0B99-49ED-424C-9673-90183BB005CDQ56915346-A4F907A9-DCC2-4C5F-BE65-5E24C71EEEA8Q57241777-7013FBAD-427A-47BA-AD23-1FF40CADC670
P2860
An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
An analysis of the benefit of ...... V IgG in a European population
@ast
An analysis of the benefit of ...... V IgG in a European population
@en
An analysis of the benefit of ...... V IgG in a European population
@nl
type
label
An analysis of the benefit of ...... V IgG in a European population
@ast
An analysis of the benefit of ...... V IgG in a European population
@en
An analysis of the benefit of ...... V IgG in a European population
@nl
prefLabel
An analysis of the benefit of ...... V IgG in a European population
@ast
An analysis of the benefit of ...... V IgG in a European population
@en
An analysis of the benefit of ...... V IgG in a European population
@nl
P2093
P2860
P50
P1433
P1476
An analysis of the benefit of ...... V IgG in a European population
@en
P2093
Cyril André
Giorgia Canellini
Katharine E A Darling
Philippe Bürgisser
P2860
P304
P356
10.1371/JOURNAL.PONE.0062980
P407
P50
P577
2013-05-07T00:00:00Z